{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:10:24Z","timestamp":1792631424953,"version":"4.5.0"},"reference-count":46,"publisher":"e-Century Publishing Corporation","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/zqzs9458","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T05:04:27Z","timestamp":1749531867000},"page":"4008-4022","source":"Crossref","is-referenced-by-count":5,"title":["Electroacupuncture improves lipid metabolism via proteome and gut microbiota profiling in obese rats"],"prefix":"10.62347","volume":"17","author":[{"given":"Xia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3390\/antibiotics11101321","article-title":"&#x201C;Growth-promoting effect&#x201D; of antibiotic use could explain the global obesity pandemic: a European survey","volume":"11","author":"Tern&#xE1","year":"2022","unstructured":"Tern&#xE1;k G, N&#xE9;meth M, Rozanovic M, M&#xE1;rovics G and Bog&#xE1;r L. &#x201C;Growth-promoting effect&#x201D; of antibiotic use could explain the global obesity pandemic: a European survey. Antibiotics (Basel) 2022; 11: 1321.","journal-title":"Antibiotics (Basel)"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/ijo.2008.102","article-title":"Global burden of obesity in 2005 and projections to 2030","volume":"32","author":"Kelly","year":"2008","unstructured":"Kelly T, Yang W, Chen CS, Reynolds K and He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008; 32: 1431-1437.","journal-title":"Int J Obes (Lond)"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1186\/s13063-022-06725-8","article-title":"The clinical evaluation of electroacupuncture combined with mindfulness meditation for overweight and obesity: study protocol for a randomized sham-controlled clinical trial","volume":"23","author":"Chung","year":"2022","unstructured":"Chung CY, Yang AWH, Foe A, Li M and Lenon GB. The clinical evaluation of electroacupuncture combined with mindfulness meditation for overweight and obesity: study protocol for a randomized sham-controlled clinical trial. Trials 2022; 23: 818.","journal-title":"Trials"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Qi X, Li Z, Han J, Liu W, Xia P, Cai X, Liu X, Liu X, Zhang J and Yu P. Multifaceted roles of T cells in obesity and obesity-related complications: a narrative review. Obes Rev 2023; 24: e13621.","DOI":"10.1111\/obr.13621"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1103953","DOI":"10.3389\/fpubh.2023.1103953","article-title":"Associations between depression and the incident risk of obesity in southwest China: a community population prospective cohort study","volume":"11","author":"Liu","year":"2023","unstructured":"Liu T, Wu B, Yao Y, Chen Y, Zhou J, Xu K, Wang N and Fu C. Associations between depression and the incident risk of obesity in southwest China: a community population prospective cohort study. Front Public Health 2023; 11: 1103953.","journal-title":"Front Public Health"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/healthcare11030433","article-title":"Pharmacological support for the treatment of obesity-present and future","volume":"11","author":"Kosmalski","year":"2023","unstructured":"Kosmalski M, Deska K, B&#x105;k B, R&#xF3;&#x17C;ycka-Kosmalska M and Pietras T. Pharmacological support for the treatment of obesity-present and future. Healthcare (Basel) 2023; 11: 433.","journal-title":"Healthcare (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/17512433.2020.1698291","article-title":"Pharmacotherapy in obesity: a systematic review and meta-analysis of randomized controlled trials of anti-obesity drugs","volume":"13","author":"Singh","year":"2020","unstructured":"Singh AK and Singh R. Pharmacotherapy in obesity: a systematic review and meta-analysis of randomized controlled trials of anti-obesity drugs. Expert Rev Clin Pharmacol 2020; 13: 53-64.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S2213-8587(17)30437-0","article-title":"Risk of suicide and non-fatal self-harm after bariatric surgery: results from two matched cohort studies","volume":"6","author":"Neovius","year":"2018","unstructured":"Neovius M, Bruze G, Jacobson P, Sj&#xF6;holm K, Johansson K, Granath F, Sundstr&#xF6;m J, N&#xE4;slund I, Marcus C, Ottosson J, Peltonen M and Carlsson LMS. Risk of suicide and non-fatal self-harm after bariatric surgery: results from two matched cohort studies. Lancet Diabetes Endocrinol 2018; 6: 197-207.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/obr.12647","article-title":"Early major complications after bariatric surgery in the USA, 2003-2014: a systematic review and meta-analysis","volume":"19","author":"Chang","year":"2018","unstructured":"Chang SH, Freeman NLB, Lee JA, Stoll CRT, Calhoun AJ, Eagon JC and Colditz GA. Early major complications after bariatric surgery in the USA, 2003-2014: a systematic review and meta-analysis. Obes Rev 2018; 19: 529-537.","journal-title":"Obes Rev"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Yin Y, Zhao Q, Li S, Jiang H, Yin C, Chen H and Zhang Y. Efficacy of acupuncture and moxibustion therapy for simple obesity in adults: a meta-analysis of randomized controlled trials. Medicine (Baltimore) 2022; 101: e31148.","DOI":"10.1097\/MD.0000000000031148"},{"key":"ref10","unstructured":"Wang JJ, Huang W, Wei D, Yang TY and Zhou ZY. Comparison of therapeutic effects of electroacupuncture and acupoint catgut embedding in redu-cing serum leptin and insulin levels in simple obesity patients. Zhen Ci Yan Jiu 2019; 44: 57-61."},{"key":"ref11","unstructured":"Chen X, Huang W, Jin Y, Hu F, Cheng X, Hong Z and Zhou Z. Prescription analysis of electroacupuncture for simple obesity based on complex network technique. Zhongguo Zhen Jiu 2018; 38: 331-336."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"11070","DOI":"10.1073\/pnas.0504978102","article-title":"Obesity alters gut microbial ecology","volume":"102","author":"RE","year":"2005","unstructured":"Ley RE, B&#xE4;ckhed F, Turnbaugh P, Lozupone CA, Knight RD and Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005; 102: 11070-11075.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.3390\/nu13113702","article-title":"The role of short-chain fatty acids in mediating very low-calorie ketogenic diet-infant gut microbiota relationships and its therapeutic potential in obesity","volume":"13","author":"Alsharairi","year":"2021","unstructured":"Alsharairi NA. The role of short-chain fatty acids in mediating very low-calorie ketogenic diet-infant gut microbiota relationships and its therapeutic potential in obesity. Nutrients 2021; 13: 3702.","journal-title":"Nutrients"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jams.2015.11.037","article-title":"Electroacupuncture improves insulin resistance by reducing neuroprotein Y\/agouti-related protein levels and inhibiting expression of protein tyrosine phosphatase 1B in diet-induced obese rats","volume":"9","author":"Liu","year":"2016","unstructured":"Liu X, He JF, Qu YT, Liu ZJ, Pu QY, Guo ST, Du J and Jiang PF. Electroacupuncture improves insulin resistance by reducing neuroprotein Y\/agouti-related protein levels and inhibiting expression of protein tyrosine phosphatase 1B in diet-induced obese rats. J Acupunct Meridian Stud 2016; 9: 58-64.","journal-title":"J Acupunct Meridian Stud"},{"key":"ref15","unstructured":"Tian HR, Zhou YD, Lu DM, Yang SR, Kang WW, Tang Q and Liang FX. Effects of electroacupuncture on the inflammatory response and intestinal flora in obese rats. Zhen Ci Yan Jiu 2024; 49: 949-956."},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"McArdle AJ and Menikou S. What is proteomics? Arch Dis Child Educ Pract Ed 2021; 106: 178-181.","DOI":"10.1136\/archdischild-2019-317434"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/mas.21763","article-title":"Collision energies: optimization strategies for bottom-up proteomics","volume":"42","author":"R&#xE9","year":"2023","unstructured":"R&#xE9;v&#xE9;sz &#xC1;, Hev&#xE9;r H, Steckel A, Schlosser G, Szab&#xF3; D, V&#xE9;key K and Drahos L. Collision energies: optimization strategies for bottom-up proteomics. Mass Spectrom Rev 2023; 42: 1261-1299.","journal-title":"Mass Spectrom Rev"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"111001","DOI":"10.1016\/j.biopha.2020.111001","article-title":"TMT-based quantitative proteomics reveals suppression of SLC3A2 and ATP1A3 expression contributes to the inhibitory role of acupuncture on airway inflammation in an OVA-induced mouse asthma model","volume":"134","author":"Tang","year":"2021","unstructured":"Tang W, Dong M, Teng F, Cui J, Zhu X, Wang W, Wuniqiemu T, Qin J, Yi L, Wang S, Dong J and Wei Y. TMT-based quantitative proteomics reveals suppression of SLC3A2 and ATP1A3 expression contributes to the inhibitory role of acupuncture on airway inflammation in an OVA-induced mouse asthma model. Biomed Pharmacother 2021; 134: 111001.","journal-title":"Biomed Pharmacother"},{"key":"ref19","unstructured":"Zhou YD, Yang SR, Wang YY, Lu W, Chen L and Liang FX. Effect of electroacupuncture at different acupoint combination on intestinal inflammatory response and intestinal flora in obese rats. Zhongguo Zhen Jiu 2022; 42: 1145-1152."},{"key":"ref20","unstructured":"Expert Group of the &#x201C;Clinical Guidelines for Traditional Chinese Medicine Weight Management&#x201D; of the China Association of Chinese Medicine and the Obesity Specialty Alliance of the Guangdong Provincial Acupuncture Society. Expert Consensus on the Diagnosis and Treatment of Obesity with Traditional Chinese Medicine. Journal of Beijing University of Traditional Chinese Medicine 2022; 45: 9."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12887-024-04668-4","article-title":"Gut microbiota profiling in obese children from Southeastern China","volume":"24","author":"Wang","year":"2024","unstructured":"Wang JJ, Zhuang PF, Lin B, Li HQ, Zheng JL, Tang WL, Ye WB, Chen XJ and Zheng MP. Gut microbiota profiling in obese children from Southeastern China. Bmc Pediatrics 2024; 24: 193.","journal-title":"Bmc Pediatrics"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Fabien M, Martin G, Lea G, Alejandra Z, Susana P, Paola N and Ramadass B. The firmicutes\/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients? Nutrients 2020; 12: 1474.","DOI":"10.3390\/nu12051474"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.3390\/microorganisms8111715","article-title":"The influence of probiotics on the firmicutes\/bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease","volume":"8","author":"Spase","year":"2020","unstructured":"Spase S, Ale&#x161; B and Borut &#x160;. The influence of probiotics on the firmicutes\/bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease. Microorganisms 2020; 8: 1715.","journal-title":"Microorganisms"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s11655-021-3303-z","article-title":"Anti-obesity and gut microbiota modulation effect of astragalus polysaccharides combined with berberine on high-fat diet-fed obese mice","volume":"29","author":"Yue","year":"2023","unstructured":"Yue SJ, Wang WX, Zhang L, Liu J, Feng WW, Gao H, Tang YP and Yan D. Anti-obesity and gut microbiota modulation effect of astragalus polysaccharides combined with berberine on high-fat diet-fed obese mice. Chin J Integr Med 2023; 29: 617-625.","journal-title":"Chin J Integr Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41577-019-0198-4","article-title":"The intestinal microbiota fuelling metabolic inflammation","volume":"20","author":"Tilg","year":"2020","unstructured":"Tilg H, Zmora N, Adolph TE and Elinav E. The intestinal microbiota fuelling metabolic inflammation. Nat Rev Immunol 2020; 20: 40-54.","journal-title":"Nat Rev Immunol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.nutres.2015.05.001","article-title":"Schisandra chinensis fruit modulates the gut microbiota composition in association with metabolic markers in obese women: a randomized, double-blind placebo-controlled study","volume":"35","author":"Song","year":"2015","unstructured":"Song MY, Wang JH, Eom T and Kim H. Schisandra chinensis fruit modulates the gut microbiota composition in association with metabolic markers in obese women: a randomized, double-blind placebo-controlled study. Nutr Res 2015; 35: 655-663.","journal-title":"Nutr Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1161\/CIRCRESAHA.115.306807","article-title":"The gut microbiome contributes to a substantial proportion of the variation in blood lipids","volume":"117","author":"JY","year":"2015","unstructured":"Fu JY, Bonder MJ, Cenit MC, Tigchelaar EF, Maatman A, Dekens JAM, Brandsma E, Marczynska J, Imhann F, Weersma RK, Franke L, Poon TW, Xavier RJ, Gevers D, Hofker MH, Wijmenga C and Zhernakova A. The gut microbiome contributes to a substantial proportion of the variation in blood lipids. Circ Res 2015; 117: 817-824.","journal-title":"Circ Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/microorganisms9020413","article-title":"Obesity, early life gut microbiota, and antibiotics","volume":"9","author":"Wilkins","year":"2021","unstructured":"Wilkins AT and Reimer RA. Obesity, early life gut microbiota, and antibiotics. Microorganisms 2021; 9: 413.","journal-title":"Microorganisms"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1038740","DOI":"10.3389\/fnut.2022.1038740","article-title":"Cordyceps guangdongensis lipid-lowering formula alleviates fat and lipid accumulation by modulating gut microbiota and short-chain fatty acids in high-fat diet mice","volume":"9","author":"Wang","year":"2022","unstructured":"Wang GZ, Sun CY, Xie BJ, Wang T, Liu HW, Chen XL, Huang QJ, Zhang CH, Li TH and Deng WQ. Cordyceps guangdongensis lipid-lowering formula alleviates fat and lipid accumulation by modulating gut microbiota and short-chain fatty acids in high-fat diet mice. Front Nutr 2022; 9: 1038740.","journal-title":"Front Nutr"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Lin HV, Frassetto A, Kowalik EJ, Nawrocki AR, Lu MFM, Kosinski JR, Hubert JA, Szeto D, Yao XR, Forrest G and Marsh DJ. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLos One 2012; 7: e35240.","DOI":"10.1371\/journal.pone.0035240"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1002\/fsn3.3607","article-title":"Tibetan tea reduces obesity brought on by a high-fat diet and modulates gut flora in mice","volume":"11","author":"He","year":"2023","unstructured":"He G, Chen TC, Huang LF, Zhang YY, Feng YJ, Liu QJ, Yin XJ, Qu SK, Yang C, Wan JH, Liang L, Yan J and Liu W. Tibetan tea reduces obesity brought on by a high-fat diet and modulates gut flora in mice. Food Sci Nutr 2023; 11: 6582-6595.","journal-title":"Food Sci Nutr"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.47836\/ifrj.31.1.18","article-title":"Tea polyphenols combined with Lactobacillus rhamnosus R5 ameliorate obesity, and alter gut microbiota composition in high-fat-diet-fed mice","volume":"31","author":"Liu","year":"2024","unstructured":"Liu M, Wang WJ, Lv QY, Xiao J, Xu QS and Jiao SR. Tea polyphenols combined with Lactobacillus rhamnosus R5 ameliorate obesity, and alter gut microbiota composition in high-fat-diet-fed mice. International Food Research Journal 2024; 31: 203-214.","journal-title":"International Food Research Journal"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41418-022-01077-x","article-title":"Blockage of PPAR&#x3B3; T166 phosphorylation enhances the inducibility of beige adipocytes and improves metabolic dysfunctions","volume":"30","author":"Yang","year":"2023","unstructured":"Yang NF, Wang YX, Tian Q, Wang QP, Lu Y, Sun LC, Wang SJ, Bei YC, Ji JG, Zhou H, Yang W, Yao PJ, Zhu WY, Sun LY, Huang ZF, Li XK and Shen PP. Blockage of PPAR&#x3B3; T166 phosphorylation enhances the inducibility of beige adipocytes and improves metabolic dysfunctions. Cell Death Differ 2023; 30: 766-778.","journal-title":"Cell Death Differ"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.3390\/jcm10143009","article-title":"Fatty acid binding protein 3 (FABP3) and apolipoprotein E4 (ApoE4) as lipid metabolism-related biomarkers of Alzheimer&#x2019;s disease","volume":"10","author":"Dulewicz","year":"2021","unstructured":"Dulewicz M, Kulczy&#x144;ska-Przybik A, S&#x142;owik A, Borawska R and Mroczko B. Fatty acid binding protein 3 (FABP3) and apolipoprotein E4 (ApoE4) as lipid metabolism-related biomarkers of Alzheimer&#x2019;s disease. J Clin Med 2021; 10: 3009.","journal-title":"J Clin Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12986-015-0012-7","article-title":"E2F8 promotes hepatic steatosis through FABP3 expression in diet-induced obesity in zebrafish","volume":"12","author":"Shimada","year":"2015","unstructured":"Shimada Y, Kuninaga S, Ariyoshi M, Zhang B, Shiina Y, Takahashi Y, Umemoto N, Nishimura Y, Enari H and Tanaka T. E2F8 promotes hepatic steatosis through FABP3 expression in diet-induced obesity in zebrafish. Nutr Metab (Lond) 2015; 12: 17.","journal-title":"Nutr Metab (Lond)"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.lfs.2009.04.004","article-title":"Upregulation of mRNA of retinoid binding protein and fatty acid binding protein by cholesterol enriched-diet and effect of ginger on lipid metabolism","volume":"84","author":"Matsuda","year":"2009","unstructured":"Matsuda A, Wang Z, Takahashi S, Tokuda T, Miura N and Hasegawa J. Upregulation of mRNA of retinoid binding protein and fatty acid binding protein by cholesterol enriched-diet and effect of ginger on lipid metabolism. Life Sci 2009; 84: 903-907.","journal-title":"Life Sci"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1254\/jphs.11097FP","article-title":"Effects of hesperidin on the progression of hypercholesterolemia and fatty liver induced by high-cholesterol diet in rats","volume":"117","author":"Wang","year":"2011","unstructured":"Wang X, Hasegawa J, Kitamura Y, Wang Z, Matsuda A, Shinoda W, Miura N and Kimura K. Effects of hesperidin on the progression of hypercholesterolemia and fatty liver induced by high-cholesterol diet in rats. J Pharmacol Sci 2011; 117: 129-138.","journal-title":"J Pharmacol Sci"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"110674","DOI":"10.1016\/j.cbi.2023.110674","article-title":"Gypenosides suppress hepatocellular carcinoma cells by blocking cholesterol biosynthesis through inhibition of MVA pathway enzyme HMGCS1","volume":"383","author":"Xiao","year":"2023","unstructured":"Xiao MY, Li FF, Xie P, Qi YS, Xie JB, Pei WJ, Luo HT, Guo M, Gu YL and Piao XL. Gypenosides suppress hepatocellular carcinoma cells by blocking cholesterol biosynthesis through inhibition of MVA pathway enzyme HMGCS1. Chem Biol Interact 2023; 383: 110674.","journal-title":"Chem Biol Interact"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Li YJ, Feng Z, Wu TL, You HX, Wang W, Liu XB and Ding L. Quinoa peptides alleviate obesity in mice induced by a high-fat diet via regulating of the PPAR-&#x3B1;\/&#x3B3; signaling pathway and gut microbiota. Mol Nutr Food Res 2023; 67: e2300258.","DOI":"10.1002\/mnfr.202300258"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"8506","DOI":"10.1021\/acs.jafc.3c08541","article-title":"Theabrownin as a potential prebiotic compound regulates lipid metabolism via the gut microbiota, microbiota-derived metabolites, and hepatic FoxO\/PPAR signaling pathways","volume":"72","author":"Xiao","year":"2024","unstructured":"Xiao Y, Yang DM, Zhang HR, Guo H, Liao Y, Lian CH, Yao YQ, Gao H and Huang YA. Theabrownin as a potential prebiotic compound regulates lipid metabolism via the gut microbiota, microbiota-derived metabolites, and hepatic FoxO\/PPAR signaling pathways. J Agric Food Chem 2024; 72: 8506-8520.","journal-title":"J Agric Food Chem"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3390\/ani9100799","article-title":"Acetate affects the process of lipid metabolism in rabbit liver, skeletal muscle and adipose tissue","volume":"9","author":"Liu","year":"2019","unstructured":"Liu L, Fu CY and Li FC. Acetate affects the process of lipid metabolism in rabbit liver, skeletal muscle and adipose tissue. Animals (Basel) 2019; 9: 799.","journal-title":"Animals (Basel)"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1021\/pr500145n","article-title":"Lipidomics reveals a link between CYP1B1 and SCD1 in promoting obesity","volume":"13","author":"Li","year":"2014","unstructured":"Li F, Jiang C, Larsen MC, Bushkofsky J, Krausz KW, Wang T, Jefcoate CR and Gonzalez FJ. Lipidomics reveals a link between CYP1B1 and SCD1 in promoting obesity. J Proteome Res 2014; 13: 2679-2687.","journal-title":"J Proteome Res"},{"key":"ref43","unstructured":"Zhao L, Liu X, Feng J, Jefcoate CR and Wang S. The role of CYP1B1 in macrophage infiltration and tissue inflammation in adult obese mice. Acta Nutrimenta Sinica 2012; 34: 242-249."},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Jia Z, Chen X, Chen J, Zhang L, Oprescu SN, Luo N, Xiong Y, Yue F and Kuang S. ACSS3 in brown fat drives propionate catabolism and its deficiency leads to autophagy and systemic metabolic dysfunction. Clin Transl Med 2022; 12: e665.","DOI":"10.1002\/ctm2.665"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s42255-019-0065-4","article-title":"Gpnmb secreted from liver promotes lipogenesis in white adipose tissue and aggravates obesity and insulin resistance","volume":"1","author":"Gong","year":"2019","unstructured":"Gong XM, Li YF, Luo J, Wang JQ, Wei J, Wang JQ, Xiao T, Xie C, Hong J, Ning G, Shi XJ, Li BL, Qi W and Song BL. Gpnmb secreted from liver promotes lipogenesis in white adipose tissue and aggravates obesity and insulin resistance. Nat Metab 2019; 1: 570-583.","journal-title":"Nat Metab"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/5\/ajtr0162287.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T08:20:01Z","timestamp":1768983601000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/5\/ajtr0162287.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/zqzs9458","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}